Celiac Disease breakthrough?

Natural protein elafin ‘promising’ in battle against gluten toxicity: Study

The natural protein elafin is less abundant in people with celiac disease which could explain gut inflammation association with the disorder, the scientists say

The human protein elafin could be delivered into the gut using a probiotic bacterium to reduce the inflammatory reaction typical of celiac disease, researchers suggest.

The patent-pending strategy has been developed by teams at the French National Institute for Agricultural Research (INRA) and the French National Institute of Health and Medical Research (INSERM) along with Canadian and Swiss colleagues.

Published online in the American Journal of Gastroenterology today (April 8), scientists delivered the elafin molecule using a food-grade strain of L. lactis successfully in mice for the first time.

INRA said findings opened up “promising prospects to treat celiac disease and gluten intolerance in general”.

The researchers said: “This molecule may have pathophysiological and therapeutic importance in gluten-related disorders.”

Elafin and its role in the gut

In the same study, in vitro testing found that elafin, a protease inhibitor, played a key role in fighting against inflammatory reactions in the gut that were typical of celiac disease, ultimately reducing gluten toxicity.

The protein prevented the destruction of the gut barrier during inflammation and interacted with enzymes responsible for the abnormal breakdown of gluten: transglutaminase-2, the researchers said.

“Our in vitro results point at an exciting novel role and specific mechanism of action of elafin in celiac disease that should be further explored.”

However, they found that the protein was less abundant in patients with celiac disease compared to healthy people; a loss that could be contributing to enhanced inflammation in celiac disease.

Delivery with a lactic bacterium strain

The lack of natural elafin molecules in those with celiac disease prompted the researchers to investigate methods of delivery. The scientists successfully delivered the protein to mice using a lactic bacterium strain Lactococcus lactis.

Findings showed that elafin delivery at the mucosal level prevented gluten-induced barrier dysfunction and inflammation.

“The use of this strain, developed by the same teams from INRA and INSERM, enables a targeted and local production of elafin, and represents a recent and innovative strategy,” INRA said.

The researchers said replacement of elafin molecules in celiac patients could have potential as adjuvant therapy in gluten-related disorders but said it was important to investigate details further.

The next step, they said, would be to define the mechanisms underlying the positive effects of elafin in celiac disease and identifying bacteria that naturally produce proteins with anti-inflammatory properties similar to elafin.

 

Source: American Journal of Gastroenterology
Published online ahead of print, April 8 2014. Doi: 10.1038/ajg.2014.48
“Novel Role of the Serine Protease Inhibitor Elafin in Gluten-Related Disorders”
Authors: HJ. Galipeau et al.

*If you are interested in celiac disease and gluten-free food development, FoodNavigator-USA is hosting an online forum 'Gluten-free in perspective' on April 30. Click HERE to register for free.

Related News

INRA wants to gain EU approval to continue its research in humans, but must convince EFSA on the use of genetically-modified probiotic bacteria as a delivery method. Photo Credit: Dee Gee, Flickr

Elafin for gluten toxicity faces GMO hurdle, says chief scientist

The development of GM wheat lines suitable for celiacs and other gluten intolerances could be a major turning point, researcher say

GM wheat presents ‘attractive’ gluten-free opportunity: Review

Gluten-free diet in pregnency linked to diabetes risk

Maternal gluten-free linked to lower diabetes risk: Mouse study

Gene marker increases celiac risk in young children; environment can’t be ignored

Gene marker increases celiac risk in young children; environment can’t be ignored

FDA gluten-free definition: All products must contain 20 ppm or less of gluten

FDA gluten-free deadline approaches

Bovine proteins can improve the overall structure of gluten-free breads - offering an interesting alternative, claim researchers

Bovine proteins give better gluten-free texture and nutrition: Study

Five groups of non-gluten proteins caused immune reactions in celiac sufferers

Not the only culprit? Celiacs react to non-gluten wheat proteins

"When I get close in conversation, what I’ll often hear a person in fear of gluten say is they want to get more vegetable protein. You can’t get more natural than wheat gluten. It’s the most important plant-based protein human civilization has ever had,” said OSU's Brett Carver, addressing what he calls "glutenoia" in society today.

‘Glutenoia’ and overblowing biotech: Wheat breeding expert debunks industry’s biggest myths

Dr Fasano: "The gluten-free diet is not the South Beach diet. For celiacs, it’s a medical necessity."

The lowdown on celiac disease, gluten sensitivity and celebrity wheat-bashing: In conversation with Dr Alessio Fasano

Obesity has a multifactorial causation and there is no scientific data to suggest that wheat consumption causes it, scientists say

No, wheat does not make people fat and sick: Scientists

Bob Quinn, founder of Kamut International, said the clear cut findings had come as a surprise and has called for further research to be conducted

Kamut wheat reduces IBS symptoms, finds human study